XJPX
7446
Market cap25mUSD
Jun 25, Last price
4,625.00JPY
1D
-0.11%
1Q
6.08%
Jan 2017
85.37%
Name
Tohoku Chemical Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Tohoku Chemical Co., Ltd., a Japanese trading enterprise, distributes an extensive array of products, primarily focusing on chemicals, medical supplies, and agricultural provisions. Its core offerings encompass pesticides, food additives, and a variety of industrial chemicals and reagents, along with their corresponding apparatus. In the healthcare sector, the company provides crucial clinical diagnostic reagents and related equipment, such as kits vital for blood and bacterial analysis that aid medical examinations and disease detection. Their medical portfolio further extends to specialized devices like clinical inspection systems and medical imaging equipment, as well as external diagnostic pharmaceuticals and various medical materials. For the food industry, Tohoku Chemical supplies food additives and processing machinery. The company also furnishes a broad spectrum of reagents for quality control, analytical testing, and hygiene applications, including cleaning agents, pesticides, and water treatment solutions. Additionally, they offer essential materials for research and development, encompassing transfer, analytical inspection, and new product innovation. Within agriculture, their provisions include pesticides, soil conditioning agents, and other farming requisites, alongside agricultural infrastructure like steel greenhouses designed for floriculture. They also market general wellness and healthcare items. Beyond these specialized areas, Tohoku Chemical Co., Ltd. is involved in the sales and maintenance of computing devices, scientific instruments, medical and educational apparatus, and measuring equipment. Furthermore, the company cultivates and sells flowers. Established in 1953, the firm maintains its headquarters in Hirosaki, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||